"HIV-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.
Descriptor ID |
D015497
|
MeSH Number(s) |
B04.820.650.589.650.350.400
|
Concept/Terms |
HIV-1- HIV-1
- Human immunodeficiency virus 1
- HIV-I
- Immunodeficiency Virus Type 1, Human
- Human Immunodeficiency Virus Type 1
|
Below are MeSH descriptors whose meaning is more general than "HIV-1".
Below are MeSH descriptors whose meaning is more specific than "HIV-1".
This graph shows the total number of publications written about "HIV-1" by people in this website by year, and whether "HIV-1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 0 | 2 |
1996 | 3 | 1 | 4 |
1997 | 3 | 0 | 3 |
1998 | 2 | 0 | 2 |
1999 | 4 | 0 | 4 |
2000 | 2 | 2 | 4 |
2001 | 1 | 1 | 2 |
2002 | 10 | 0 | 10 |
2003 | 10 | 1 | 11 |
2004 | 11 | 6 | 17 |
2005 | 15 | 5 | 20 |
2006 | 11 | 3 | 14 |
2007 | 9 | 1 | 10 |
2008 | 21 | 4 | 25 |
2009 | 15 | 2 | 17 |
2010 | 14 | 3 | 17 |
2011 | 18 | 4 | 22 |
2012 | 20 | 2 | 22 |
2013 | 24 | 4 | 28 |
2014 | 16 | 2 | 18 |
2015 | 20 | 4 | 24 |
2016 | 29 | 10 | 39 |
2017 | 382 | 147 | 529 |
2018 | 340 | 106 | 446 |
2019 | 99 | 36 | 135 |
2020 | 9 | 19 | 28 |
2021 | 12 | 6 | 18 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV-1" by people in Profiles.
-
Sustaining Early Infant Diagnosis of HIV During Coronavirus Disease 2019 Pandemic: Experience Collecting Dry Blood Spots Samples at Home From HIV-exposed Infants in Nigeria. Pediatr Infect Dis J. 2021 12 01; 40(12):e529-e530.
-
A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter. Emerg Microbes Infect. 2021 Dec; 10(1):894-904.
-
Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus. Emerg Microbes Infect. 2021 Dec; 10(1):810-821.
-
Virus-associated ribozymes and nano carriers against COVID-19. Artif Cells Nanomed Biotechnol. 2021 Dec; 49(1):204-218.
-
A High Percentage of People With Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 11 02; 73(9):e2845-e2846.
-
COVID-19-Related Stressors, Sex Behaviors, and HIV Status Neutral Care Among Black Men Who Have Sex With Men and Transgender Women in Chicago, USA. J Acquir Immune Defic Syndr. 2021 11 01; 88(3):261-271.
-
Risk Factors for Hospitalization in People With HIV and COVID-19. J Acquir Immune Defic Syndr. 2021 11 01; 88(3):e22.
-
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clin Microbiol Infect. 2021 Dec; 27(12):1851-1855.
-
Targeting Ribosomal Frameshifting as an Antiviral Strategy: From HIV-1 to SARS-CoV-2. Acc Chem Res. 2021 09 07; 54(17):3349-3361.
-
Significance of the placental barrier in antenatal viral infections. Biochim Biophys Acta Mol Basis Dis. 2021 12 01; 1867(12):166244.